Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Bacterial Infections and Mycoses

  Free Subscription


10.10.2022

1 Am J Med
2 Antimicrob Agents Chemother
1 BMC Pediatr
2 BMJ
13 Clin Infect Dis
1 Eur J Clin Microbiol Infect Dis
11 J Antimicrob Chemother
2 J Immunol
2 J Infect Dis
1 JAMA
1 Nature
1 Neurologia (Engl Ed)
4 Pediatrics
1 PLoS Negl Trop Dis
8 PLoS One
2 PLoS Pathog


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Med

  1. MADAN R, Muthukumar V, Premji S, Khan R, et al
    Murine Typhus-Induced Myocarditis.
    Am J Med. 2022;135:e397-e398.
    PubMed        


    Antimicrob Agents Chemother

  2. PI R, Chen X, Meng J, Liu Q, et al
    Drug Degradation Caused by mce3R Mutations Confers Contezolid (MRX-I) Resistance in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2022 Oct 3:e0103422. doi: 10.1128/aac.01034.
    PubMed         Abstract available

  3. RAMBACH G, Striednig B, Neurauter M, Hermann M, et al
    Indications that the Antimycotic Drug Amphotericin B Enhances the Impact of Platelets on Aspergillus.
    Antimicrob Agents Chemother. 2022 Oct 3:e0068122. doi: 10.1128/aac.00681.
    PubMed         Abstract available


    BMC Pediatr

  4. CHENG J, Li Q, Zhang G, Xu H, et al
    Time to appropriate antimicrobial therapy serves an independent prognostic indicator in children with nosocomial Klebsiella pneumoniae bloodstream infection.
    BMC Pediatr. 2022;22:568.
    PubMed         Abstract available


    BMJ

  5. TAYLOR L
    Haiti's hospitals plan to close amid fuel shortages.
    BMJ. 2022;379:o2379.
    PubMed        

  6. DYER O
    Syphilis and gonorrhoea cases soar in US.
    BMJ. 2022;378:o2355.
    PubMed        


    Clin Infect Dis

  7. KAIPILYAWAR V, Zhao Y, Wang X, Joseph NM, et al
    Development and Validation of a Parsimonious Tuberculosis Gene Signature Using the digital NanoString nCounter Platform.
    Clin Infect Dis. 2022;75:1022-1030.
    PubMed         Abstract available

  8. HEWISON C, Khan U, Bastard M, Lachenal N, et al
    Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort.
    Clin Infect Dis. 2022;75:1006-1013.
    PubMed         Abstract available

  9. NIEUWENBURG SA, Zondag HCA, Bruisten SM, Jongen VW, et al
    Detection of Treponema pallidum DNA during early syphilis stages in peripheral blood, oropharynx, ano-rectum and urine as a proxy for transmissibility.
    Clin Infect Dis. 2022 Jan 25. pii: 6515376. doi: 10.1093.
    PubMed         Abstract available

  10. LAKE SJ, Kaldor JM, Hardy M, Engelman D, et al
    Mass Drug Administration for the Control of Scabies: A Systematic Review and Meta-analysis.
    Clin Infect Dis. 2022;75:959-967.
    PubMed         Abstract available

  11. WESTON EJ, Heidenga BL, Farley MM, Tunali A, et al
    Surveillance for Disseminated Gonococcal Infections, Active Bacterial Core surveillance (ABCs) - United States, 2015-2019.
    Clin Infect Dis. 2022 Jan 28. pii: 6516834. doi: 10.1093.
    PubMed         Abstract available

  12. ROCK C, Abosi O, Bleasdale S, Colligan E, et al
    Clinical Decision Support Systems to Reduce Unnecessary Clostridioides difficile Testing Across Multiple Hospitals.
    Clin Infect Dis. 2022;75:1187-1193.
    PubMed         Abstract available

  13. GAREY KW, McPherson J, Dinh AQ, Hu C, et al
    Efficacy, Safety, Pharmacokinetics, and Microbiome Changes of Ibezapolstat in Adults with Clostridioides difficile Infection: A Phase 2a Multicenter Clinical Trial.
    Clin Infect Dis. 2022;75:1164-1170.
    PubMed         Abstract available

  14. PERNICIARO S, van der Linden M, Weinberger DM
    Re-emergence of Invasive Pneumococcal Disease in Germany during the Spring and Summer of 2021.
    Clin Infect Dis. 2022 Feb 7. pii: 6523816. doi: 10.1093.
    PubMed         Abstract available

  15. CERTAN M, Garcia Garrido HM, Wong G, Heijmans J, et al
    Incidence and Predictors of Community-Acquired Pneumonia in Patients With Hematological Cancers Between 2016 and 2019.
    Clin Infect Dis. 2022;75:1046-1053.
    PubMed         Abstract available

  16. O'DONNELL M, Eller AW, Waxman EL, Clancy CJ, et al
    Screening for Ocular Candidiasis Among Patients With Candidemia: Is It Time to Change Practice?
    Clin Infect Dis. 2022;75:1092-1096.
    PubMed         Abstract available

  17. SKINNER AM, Petrella L, Spandoni S, Serna-Perez F, et al
    Can Clostridium innocuum Masquerade as Clostridioides difficile?
    Clin Infect Dis. 2022;75:1268-1269.
    PubMed        

  18. ROBINSON JL
    Cost-Effective Treatment of Clostridiodes difficile Infection.
    Clin Infect Dis. 2022;75:1269.
    PubMed        

  19. BREAZZANO MP, Bond JB, Lum F, Olsen TW, et al
    Screening for Ocular Findings Among Patients With Candidemia: Isn't It Time to Change Practice?
    Clin Infect Dis. 2022;75:1270-1271.
    PubMed        


    Eur J Clin Microbiol Infect Dis

  20. FERNANDES L, Ribeiro R, Henriques M, Rodrigues ME, et al
    Candida auris, a singular emergent pathogenic yeast: its resistance and new therapeutic alternatives.
    Eur J Clin Microbiol Infect Dis. 2022 Oct 6. pii: 10.1007/s10096-022-04497.
    PubMed         Abstract available


    J Antimicrob Chemother

  21. LASARTE-MONTERRUBIO C, Fraile-Ribot PA, Vazquez-Ucha JC, Cabot G, et al
    Activity of cefiderocol, imipenem/relebactam, cefepime/taniborbactam and cefepime/zidebactam against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2022;77:2809-2815.
    PubMed         Abstract available

  22. PATEL S, Chapagain M, Mason C, Gingrich M, et al
    Potency of the novel PolC DNA polymerase inhibitor CRS0540 in a disseminated Listeria monocytogenes intracellular hollow-fibre model.
    J Antimicrob Chemother. 2022;77:2876-2885.
    PubMed         Abstract available

  23. LONGSHAW CM, Santerre Henriksen A, Slover C, Yamano Y, et al
    Comment on: Bacteraemia with an MBL-producing Klebsiella pneumoniae: treatment and the potential role of cefiderocol heteroresistance.
    J Antimicrob Chemother. 2022;77:2895-2896.
    PubMed        

  24. KADO J, Salman S, Hand R, O'Brien M, et al
    Population pharmacokinetic study of benzathine penicillin G administration in Indigenous children and young adults with rheumatic heart disease in the Northern Territory, Australia.
    J Antimicrob Chemother. 2022;77:2679-2682.
    PubMed         Abstract available

  25. EMERAUD C, Godmer A, Girlich D, Vanparis O, et al
    Activity of mecillinam against carbapenem-resistant Enterobacterales.
    J Antimicrob Chemother. 2022 Jul 11. pii: 6639593. doi: 10.1093.
    PubMed         Abstract available

  26. DE LAUZANNE A, Sreng N, Foucaud E, Sok T, et al
    Prevalence and factors associated with faecal carriage of extended-spectrum beta-lactamase-producing Enterobacterales among peripartum women in the community in Cambodia.
    J Antimicrob Chemother. 2022;77:2658-2666.
    PubMed         Abstract available

  27. VOLLAND H, Balleste-Delpierre C, Szabo D, Gonzalez C, et al
    Rapid detection of CTX-M-type ESBLs and carbapenemases directly from biological samples using the BL-DetecTool.
    J Antimicrob Chemother. 2022;77:2867-2875.
    PubMed         Abstract available

  28. BRENCIANI A, Morroni G, Schwarz S, Giovanetti E, et al
    Oxazolidinones: mechanisms of resistance and mobile genetic elements involved.
    J Antimicrob Chemother. 2022;77:2596-2621.
    PubMed         Abstract available

  29. GROHS P, Vilfaillot A, Zahar JR, Barbut F, et al
    Faecal carriage of multidrug-resistant bacteria and associated risk factors: results from a point prevalence study.
    J Antimicrob Chemother. 2022;77:2667-2678.
    PubMed         Abstract available

  30. SHRESTHA R, Luterbach CL, Dai W, Komarow L, et al
    Characteristics of community-acquired carbapenem-resistant Enterobacterales.
    J Antimicrob Chemother. 2022;77:2763-2771.
    PubMed         Abstract available

  31. TANG K, Coombs S, Gwee A
    Frequency of drug-induced liver injury in children receiving anti-staphylococcal penicillins.
    J Antimicrob Chemother. 2022 Oct 7. pii: 6751029. doi: 10.1093.
    PubMed         Abstract available


    J Immunol

  32. MENOUSEK J, Horn CM, Heim CE, Van Roy Z, et al
    Transcriptional Profiling of Phagocytic Leukocytes and Microglia Reveals a Critical Role for Reactive Oxygen Species in Biofilm Containment during Staphylococcus aureus Craniotomy Infection.
    J Immunol. 2022 Oct 3. pii: jimmunol.2200503. doi: 10.4049/jimmunol.2200503.
    PubMed         Abstract available

  33. IDOL RA, Bhattacharya S, Huang G, Song Z, et al
    Neutrophil and Macrophage NADPH Oxidase 2 Differentially Control Responses to Inflammation and to Aspergillus fumigatus in Mice.
    J Immunol. 2022 Oct 3. pii: jimmunol.2200543. doi: 10.4049/jimmunol.2200543.
    PubMed         Abstract available


    J Infect Dis

  34. LAMOTH F, Lewis RE, Walsh TJ, Kontoyiannis DP, et al
    Navigating the uncertainties of COVID-19 associated aspergillosis (CAPA): A comparison with influenza associated aspergillosis (IAPA).
    J Infect Dis. 2021 Mar 26. pii: 6189669. doi: 10.1093.
    PubMed         Abstract available

  35. SU X, Le W, Zhu X, Li S, et al
    Neisseria gonorrhoeae infection in women increases with rising numbers of gonococci in partners: Chlamydia coinfection in women increases gonococcal burden.
    J Infect Dis. 2022 Oct 6. pii: 6750085. doi: 10.1093.
    PubMed         Abstract available


    JAMA

  36. ADVANI SD, Claeys K
    Cefepime/Enmetazobactam for Complicated Urinary Tract Infections.
    JAMA. 2022;328:1299-1301.
    PubMed        


    Nature

  37. LAZAR V, Snitser O, Barkan D, Kishony R, et al
    Antibiotic combinations reduce Staphylococcus aureus clearance.
    Nature. 2022 Oct 5. pii: 10.1038/s41586-022-05260.
    PubMed         Abstract available


    Neurologia (Engl Ed)

  38. BEJARANO-FERREYRA JH, Aguirre-Quispe W, Guevara-Silva E, Torres-Ramirez L, et al
    Positive anti-GQ1b Miller Fisher syndrome and Escherichia coli infection: A case report.
    Neurologia (Engl Ed). 2022;37:700-702.
    PubMed        


    Pediatrics

  39. VAIDYA R, Yi JX, O'Shea TM, Jensen ET, et al
    Long-Term Outcome of Necrotizing Enterocolitis and Spontaneous Intestinal Perforation.
    Pediatrics. 2022 Oct 6. pii: 189675. doi: 10.1542/peds.2022-056445.
    PubMed         Abstract available

  40. VAN HENTENRYCK M, Schroeder AR, McCulloh RJ, Stave CD, et al
    Duration of Antibiotic Therapy for Bacterial Meningitis in Young Infants: A Systematic Review.
    Pediatrics. 2022 Oct 5. pii: 189672. doi: 10.1542/peds.2022-057510.
    PubMed         Abstract available

  41. KAPLAN SL
    Can Duration of Antibiotic Therapy for Bacterial Meningitis in Infants Be Shortened?
    Pediatrics. 2022 Oct 5. pii: 189671. doi: 10.1542/peds.2022-058164.
    PubMed        

  42. MAHAJAN P, VanBuren JM, Tzimenatos L, Cruz AT, et al
    Serious Bacterial Infections in Young Febrile Infants With Positive Urinalysis Results.
    Pediatrics. 2022 Sep 13. pii: 189487. doi: 10.1542/peds.2021-055633.
    PubMed         Abstract available


    PLoS Negl Trop Dis

  43. ZHAO X, Guo J, Jia X, Yang Y, et al
    Internalization of Leptospira interrogans via diverse endocytosis mechanisms in human macrophages and vascular endothelial cells.
    PLoS Negl Trop Dis. 2022;16:e0010778.
    PubMed         Abstract available


    PLoS One

  44. G SG, Mannam P, Kumar V, George T, et al
    Absence of posterior pituitary bright spot in adults with CNS tuberculosis: A case-control study.
    PLoS One. 2022;17:e0275460.
    PubMed         Abstract available

  45. BIGGS SL, Jennison AV, Bergh H, Graham R, et al
    Limited evidence of patient-to-patient transmission of Staphylococcus aureus strains between children with cystic fibrosis, Queensland, Australia.
    PLoS One. 2022;17:e0275256.
    PubMed         Abstract available

  46. MALE HERE RR, Ryan E, Breslin P, Frankena K, et al
    Revisiting the relative effectiveness of slaughterhouses in Ireland to detect tuberculosis lesions in cattle (2014-2018).
    PLoS One. 2022;17:e0275259.
    PubMed         Abstract available

  47. KHALIL FO, Taj MB, Ghonaim EM, Abed El-Sattar S, et al
    Hydrothermal assisted biogenic synthesis of silver nanoparticles: A potential study on virulent candida isolates from COVID-19 patients.
    PLoS One. 2022;17:e0269864.
    PubMed         Abstract available

  48. DE HAAS P, Yenew B, Diriba G, Amare M, et al
    The Simple One-step stool processing method for detection of Pulmonary tuberculosis: A study protocol to assess the robustness, stool storage conditions and sampling strategy for global implementation and scale-up.
    PLoS One. 2022;17:e0264103.
    PubMed         Abstract available

  49. SEWUNET T, K K S, Nguyen HH, Sithivong N, et al
    Fecal carriage and clonal dissemination of blaNDM-1 carrying Klebsiella pneumoniae sequence type 147 at an intensive care unit in Lao PDR.
    PLoS One. 2022;17:e0274419.
    PubMed         Abstract available

  50. NELSON EC, Wang CH, Huang G, Kuo NW, et al
    Institutional factors associated with the incidence rates of central line-associated bloodstream infection in California community hospitals.
    PLoS One. 2022;17:e0274436.
    PubMed         Abstract available

  51. SAYLOR TC, Casselli T, Lethbridge KG, Moore JP, et al
    Borrelia burgdorferi, the Lyme disease spirochete, possesses genetically-encoded responses to doxycycline, but not to amoxicillin.
    PLoS One. 2022;17:e0274125.
    PubMed         Abstract available


    PLoS Pathog

  52. KUMAR R, Taylor JC, Jain A, Jung SY, et al
    Modulation of the extracellular matrix by Streptococcus gallolyticus subsp. gallolyticus and importance in cell proliferation.
    PLoS Pathog. 2022;18:e1010894.
    PubMed         Abstract available

  53. CHOWDHARY A, Singh A, Kaur A, Khurana A, et al
    The emergence and worldwide spread of the species Trichophyton indotineae causing difficult-to-treat dermatophytosis: A new challenge in the management of dermatophytosis.
    PLoS Pathog. 2022;18:e1010795.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Bacterial Infections and Mycoses is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: